...
首页> 外文期刊>International journal of oncology >Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells
【24h】

Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells

机译:功能获得性microRNA筛选可鉴定miR-193a调节上皮性卵巢癌细胞的增殖和凋亡

获取原文

摘要

MicroRNAs (miRNAs) are a small class of non?coding RNAs that negatively regulate gene expression, and are considered as new therapeutic targets for treating cancer. In this study, we performed a gain-of-function screen using miRNA mimic library (319 miRNA species) to identify those affecting cell proliferation in human epithelial ovarian cancer cells (A2780). We discovered a number of miRNAs that increased or decreased the cell viability of A2780 cells. Pro-proliferative and anti-proliferative miRNAs include oncogenic miR-372 and miR-373, and tumor suppressive miR-124a, miR-7, miR-192 and miR-193a, respectively. We found that overexpression of miR-124a, miR-192, miR-193a and miR?193b inhibited BrdU incorporation in A2780 cells, indicating that these miRNAs affected the cell cycle. Overexpression of miR?193a and miR-193b induced an activation of caspase?3/7, and resulted in apoptotic cell death in A2780 cells. A genome?wide gene expression analysis with miR-193a-transfected A2780 cells led to identification of ARHGAP19, CCND1, ERBB4, KRAS and MCL1 as potential miR-193a targets. We demonstrated that miR-193a decreased the amount of MCL1 protein by binding 3'UTR of its mRNA. Our study suggests the potential of miRNA screens to discover miRNAs as therapeutic tools to treat ovarian cancer.
机译:微小RNA(miRNA)是一小类非编码RNA,它们负面调节基因表达,被认为是治疗癌症的新靶点。在这项研究中,我们使用miRNA模仿文库(319个miRNA物种)进行了功能增益筛选,以鉴定那些影响人上皮性卵巢癌细胞(A2780)细胞增殖的物质。我们发现了许多增加或减少A2780细胞活力的miRNA。增殖性和抗增殖性miRNA分别包括致癌miR-372和miR-373,以及抑癌性miR-124a,miR-7,miR-192和miR-193a。我们发现,miR-124a,miR-192,miR-193a和miR?193b的过表达抑制了A2780细胞中BrdU的掺入,表明这些miRNA影响了细胞周期。 miR?193a和miR-193b的过表达诱导了caspase?3/7的活化,并导致A2780细胞凋亡。使用miR-193a转染的A2780细胞进行全基因组全基因表达分析,结果确定了ARHGAP19,CCND1,ERBB4,KRAS和MCL1作为潜在的miR-193a靶标。我们证明了miR-193a通过结合其mRNA的3'UTR减少了MCL1蛋白的量。我们的研究表明,miRNA筛选发现miRNA作为治疗卵巢癌的治疗工具的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号